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Background
Drug hypersensitivity is one of the most frequent reasons
for consultations with an allergist in Brazil. However,
drug hypersensitivity epidemiology data in children is
scarce. The aim of this study was to investigate children
reporting suspected drug hypersensitivity reaction (DHR).
Methods
From June 2011 to December 2013 a prospective observa-
tional study was implemented in 4 allergology units from
different regions of Brazil. Children reporting DHR were
evaluated using a modified ENDA questionnaire, and a
standardized diagnostic work up was performed.
Results
Ninety patients were evaluated, 54 male, with a median
age of 6 years. Personal history of atopy was reported in
65 and previous DHR in 9. Cutaneous manifestations were
observed in 86 – urticaria and/or angioedema in 71 and
macular or maculopapular exanthema in 15. Other symp-
toms reported were: respiratory (25), gastrointestinal (8),
cardiovascular (5). The interval between dose and reaction
was less than 1 hour in 38 subjects. Mild reaction was
observed in 32 patients and moderate in 55. Fever and/or
viral infection were present in 61 patients during or just
before the reaction. The majority of subjects were treated
in emergency units (79). More than one drug was sus-
pected as a trigger in 50 children (NSAIDs in 50%,
beta-lactam antibiotics in 31% and other antibiotics in
8.5%). Sixteen skin tests (prick and intradermal) were per-
formed and were all negative but one with amoxicilin.
Drug provocation tests were positive in 4 of 51 tests -
NSAIDs 29 (4 positive), beta-lactam antibiotics 20 and
others 4. Sixty-one reactions were possible or probable
related with the suspected drug, but in 25 this relation was
unlikely.
Conclusions
Children with a suspected history must be fully investi-
gated to confirm or exclude the diagnosis of DHR.
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